Trevigen/超氧化物歧化酶检测试剂盒(试管)/7500-100-K/100反应

价格
¥10560.00
货号:7500-100-K
浏览量:127
品牌:Trevigen
服务
全国联保
正品保证
正规发票
签订合同
商品描述

Description

IntheSuperoxideDismutaseAssay,ionsgeneratedfromtheconversionofxanthinetouricacid,andhydrogenperoxidebyxanthineoxidase(XOD),convertNBTtoNBT-diformazan.NBT-diformazanabsorbslightat550nm.SODsreducesuperoxideionconcentrationsandtherebylowertherateofNBT-diformazanformation.TheextentofreductionintheappearanceofNBT-diformazanisameasureofSODactivitypresentinexperimentalsamples.Theassayisfreeofinterferencebyothercatalyticactivities,andisidealforassayingSODinmammaliancelllysates.Thekitcontainstheproperlysisbufferandthereagentsneededfor100experimentaltests,50positivecontrols,and50negativecontrols.UnlikesomeotherassaykitsforSOD,thissystemisnotgreatlydisturbedbytracemetals.Eachassayrequiresonlyaboutfiveminutes,andafterasimplecalculation,thepercentinhibitionoftheformationofNBT-diformazanbySODisconvertedtotherelativeactivityofthesample.

FEATURES:

  • Suitableformammaliancells.
  • Eachsampletakesonly5minutes.
  • ContainsSODfor50positivecontrols.
  • Suitablefortheassayof(Mn2+)-SOD,(Fe2+)-SOD,and(Cu/Zn)SOD.

APPLICATIONS:

CalculatingSODactivitybymeasuringthereductionofNBT-diformazanincellextracts.

 

Catalog#7500-100-Kincludes:
CatalogNumberDescriptionQty
7500-100-01SuperOxideDismutase1
7500-100-05XODSolution1
7500-100-0225XSODReactionBuffer1
7500-100-03XanthineSolution1
7500-100-04NBTSolution1
7500-100-0620XCellLysisSolution1

RosiglitazoneCausesCardiotoxicityviaPeroxisomeProliferator-ActivatedReceptor{gamma}-IndependentMitochondrialOxidativeStressinMouseHearts
HuameiHe,HaiTao,HuiXiong,ShengZhongDuan,FrancisX.McGowan,Jr.,RichardM.Mortensen,andJamesA.Balschi
Toxicol.Sci.,Apr2014;138:468–481.
http://toxsci.oxfordjournals.org/cgi/content/abstract/138/2/468


Protectiveactivityofanovelresveratrolanalogue,HS-1793,againstDNAdamagein137Cs-irrADIatedCHO-K1cells

Jeong,M.H.,Yang,K.M.,Jeong,D.H.,Lee,C.G.,Oh,S.J.,Jeong,S.K.,Lee,K.W.,Jo,Y.R.andJo,W.S.
J.RadiatRes,May2014;55:464–47
http://jrr.oxfordjournals.org/cgi/content/abstract/55/3/464

Trevigen,Inc.是一家发展迅速的生物技术公司,致力于开发用于癌症研究,药物发现,遗传毒理学,再生医学和干细胞研究的产品和技术。我们提供试剂盒和试剂,用于研究DNA损伤和修复,细胞凋亡,氧化应激,癌细胞行为,3D培养和干细胞。该公司获得了美国国立卫生研究院(National Institutes of Health)多项SBIR资助。